Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,140.72
2,154.23
1,936.79
1,630.46
1,374.10
1,281.36
1,005.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,140.72
2,154.23
1,936.79
1,630.46
1,374.10
1,281.36
1,005.70
Raw Material Cost
1,123.14
1,154.90
928.96
761.78
653.46
523.10
328.69
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
25.25
27.04
26.73
21.07
17.59
9.56
4.57
Selling and Distribution Expenses
739.70
693.31
710.90
630.35
524.12
604.95
556.06
Other Expenses
12.59
9.89
6.49
4.28
2.40
3.44
3.17
Total Expenditure (Excl Depreciation)
2,013.96
1,974.14
1,731.50
1,456.02
1,219.17
1,172.05
921.06
Operating Profit (PBDIT) excl Other Income
126.8
180.10000000000002
205.3
174.4
154.9
109.3
84.60000000000001
Other Income
44.49
23.02
15.32
10.35
6.67
3.99
9.12
Operating Profit (PBDIT)
226.80
258.12
259.58
209.66
182.51
132.08
114.95
Interest
25.25
27.04
26.73
21.07
17.59
9.56
4.57
Exceptional Items
0.00
1.76
0.05
0.02
0.31
0.23
-0.01
Gross Profit (PBDT)
1,017.58
999.33
1,007.83
868.68
720.65
758.26
677.02
Depreciation
62.00
57.95
42.16
29.00
23.01
20.66
22.45
Profit Before Tax
139.55
174.89
190.74
159.61
142.22
102.08
87.92
Tax
24.01
23.69
22.61
19.66
21.81
18.21
13.65
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
84.16
135.01
141.37
118.84
103.00
79.73
73.56
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
84.16
135.01
141.37
118.84
103.00
79.73
73.56
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
22.25
16.33
25.07
21.06
17.15
3.52
0.61
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
106.41
151.34
166.44
139.90
120.15
83.25
74.17
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,395.61
1,354.19
1,266.62
1,158.11
1,071.56
989.25
930.24
Earnings per share (EPS)
0.29
0.47
0.5
0.42
0.36
0.28
0.26
Diluted Earnings per share
0.29
0.47
0.5
0.42
0.36
0.28
0.26
Operating Profit Margin (Excl OI)
5.62%
8.22%
10.43%
10.45%
11.12%
8.38%
8.29%
Gross Profit Margin
9.42%
10.81%
12.03%
11.57%
12.02%
9.58%
10.97%
PAT Margin
3.93%
6.27%
7.3%
7.29%
7.5%
6.22%
7.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -0.63% vs 11.22% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -29.68% vs -9.07% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -22.46% vs -3.77% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -6.67% vs 1.12% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Jiangsu Lianhuan Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
2,140.72
0
2,140.72
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,140.72
0
2,140.72
Raw Material Cost
1,123.14
0
1,123.14
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
25.25
0
25.25
Selling and Distribution Expenses
739.70
0
739.70
Other Expenses
12.59
0.00
12.59
Total Expenditure (Excl Depreciation)
2,013.96
0
2,013.96
Operating Profit (PBDIT) excl Other Income
126.77
0.00
126.77
Other Income
44.49
0
44.49
Operating Profit (PBDIT)
226.80
0
226.80
Interest
25.25
0
25.25
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1,017.58
0
1,017.58
Depreciation
62.00
0
62.00
Profit Before Tax
139.55
0
139.55
Tax
24.01
0
24.01
Provisions and contingencies
0
0
0.00
Profit After Tax
84.16
0
84.16
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
84.16
0
84.16
Share in Profit of Associates
0
0
0.00
Minority Interest
22.25
0
22.25
Other related items
0.00
0.00
0.00
Consolidated Net Profit
106.41
0
106.41
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,395.61
0
1,395.61
Earnings per share (EPS)
0.29
0
0.29
Diluted Earnings per share
0.29
0
0.29
Operating Profit Margin (Excl OI)
5.62%
0%
0.00
5.62%
Gross Profit Margin
9.42%
0%
0.00
9.42%
PAT Margin
3.93%
0%
0.00
3.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 214.07 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -0.63% vs 11.22% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 10.64 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -29.68% vs -9.07% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.23 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -22.46% vs -3.77% in Dec 2023
Annual - Interest
Interest 2.52 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -6.67% vs 1.12% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.62%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






